Skip to main content
TipRanks
Go Ultimate75% OFF

CytoMed Therapeutics Limited (GDTC) Income Statement

23 Followers

CytoMed Therapeutics Limited Income Statement

Last quarter (Q2 2026), CytoMed Therapeutics Limited's total revenue was S$157.29K, an increase of 0.90% from the same quarter last year. In Q2, CytoMed Therapeutics Limited's net income was S$-1.77M. See CytoMed Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Mar 24Dec 22Dec 21
S$ 324.39KS$ 69.50KS$ 0.00S$ 0.00S$ 0.00
S$ 256.39KS$ 52.38KS$ -4.36MS$ 0.00S$ 110.29K
S$ 5.05MS$ 3.65MS$ 0.00S$ 2.34MS$ 1.27M
Depreciation and AmortizationS$ 401.58KS$ 335.36KS$ 381.15KS$ 392.87KS$ 329.88K
S$ -3.57MS$ -2.17MS$ -3.70MS$ -2.61MS$ -1.56M
S$ -4.79MS$ -3.60MS$ -4.36MS$ -2.34MS$ -1.16M
S$ 792.74KS$ 1.08MS$ 228.51KS$ -789.97KS$ -900.44K
S$ -4.00MS$ -2.52MS$ -4.13MS$ -3.13MS$ -2.06M
S$ -3.98MS$ -2.52MS$ -4.13MS$ -3.13MS$ -2.07M
Per Share Metrics
Basic EPSS$ -0.34S$ -0.22S$ -0.39S$ -0.40S$ -0.30
Diluted EPSS$ -0.34S$ -0.22S$ -0.39S$ -0.40S$ -0.30
Weighted Average Shares Outstanding11.65M11.54M10.63M7.92M6.93M
Weighted Average Shares Outstanding (Diluted)11.65M11.54M10.63M7.92M6.93M

Currency in SGD

CytoMed Therapeutics Limited Earnings and Revenue History

-5M-2.5M02.5M-4000 %-3000 %-2000 %-1000 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin